19^th World Gastroenterologists Summit October 14-15, 2019 Sydney, Australia

Track 1: Advances in Gastroenterology

Flexible sigmoidoscopy is one of several screening modalities recommended by the US Preventive Services Task Force for colorectal cancer (CRC) screening. However, sigmoidoscopy is less effective in detecting lesions at the right side of the colon than the left side, and right-sided lesions are more common in older women. A study that pooled results from three randomized trials comparing screening by sigmoidoscopy with no screening found that the incidence of CRC at 10 to 12 years was decreased in men but in women, only in those younger than 60 years. Current screening recommendations do not indicate gender-based preferences for screening options.

Track 2: Paediatrics Gastroenterology

Pediatric gastroenterologists treat children from the new born period through the teen years. They choose pediatric care the core of their medical practice, which provides extensive experience specially in the care of infants, children, and teens. Pediatric gastroenterologists provide treatment for the following conditions.

Bleeding from the gastrointestinal tract, Lactose intolerance, Food allergies or intolerances, Severe or complicated gastroesophageal reflux disease (reflux or GERD), Inflammatory bowel disease, bowel syndrome, Liver ailments, Acute or chronic abdominal pain, Vomiting, Chronic constipation, Chronic or severe diarrhea.

Track 3: Gastrointestinal Disorder

Gastrointestinal disorders refer to diseases in the gastrointestinal tract, namely the oesophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas. A functional disorder or disease occurs when the abnormality in the body works. Globus - a sensation of a lump, something stuck, or a tightness in the throat, Functional heartburn - persistent burning sensation in the absence of gastroesophageal reflux disease (GERD), a motility disorder, or a structural explanation, Functional dysphagia - the sensation of difficulty swallowing, Reflux hypersensitivity, Functional dyspepsia - pain or discomfort located in the upper abdomen, Belching disorders, Nausea and vomiting, Rumination syndrome,  inflammatory bowel syndrome, Infant rumination syndrome, constipation.    

Track 4: Gastrointestinal Diseases during Pregnancy

Gastrointestinal (GI) disease also represents during pregnancy. Some women have GI disorders that are unique to pregnancy. Other pregnant patients present with chronic GI disorders that require special care during pregnancy. Understanding the prevalence of various GI disorders is necessary to optimize care for these patients. Nausea, with or without vomiting, is common in early pregnancy, Other causes of nausea in pregnancy include urinary tract infections, gastroenteritis, peptic ulcer disease, pancreatitis, biliary tract disease, hepatitis, appendicitis, adrenal insufficiency, and increased intracranial pressure. In later pregnancy, considerations also include hydramnios, preeclampsia, and onset of labor.

Track 5: Gastrointestinal Oncology

Gastrointestinal oncology refers to malignant conditions of the gastrointestinal tract (GI tract) and accessory organs of digestion, including the oesophagus, stomach, biliary system, pancreas, small and large intestine, rectum and anus. The symptoms relate to the organ affected and can include obstruction which leads to difficulty swallowing or defecating, abnormal bleeding. The treatment requires endoscopy, followed by biopsy of suspicious tissue. The treatment depends on the location of the tumor, as well as the type of cancer cell and whether it has invaded other tissues or spread elsewhere. These factors also determine the prognosis.

Track 6: Gastrointestinal Surgery

Gastrointestinal surgery, also referred to as upper GI surgery, which refers to a practise of surgery that mainly focuses on the upper parts of the alimentary tract. A pancreaticoduodenectomy or Kausch-Whipple procedure is a major surgical operation which involves the removal of the head of the pancreas, the duodenum, the proximal jejunum, gallbladder, and part of the stomach. This surgery is mostly performed to remove cancerous tumours of the head of the pancreas and other related organs (Ampulla of Vater, duodenum or bile duct). Hepatectomy is the surgical resection complete or a part of the liver.

Track 7:  Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC), often reffered to as malignant hepatoma. It is the most common type of hepato cancer. Most cases of hepato cancer are as a result of either a viral hepatitis infection (hepatitis B or C), metabolic toxins such as alcohol or aflatoxin, conditions like hemochromatosis. Treatment options for HCC and prognosis are dependent on many factors but especially on tumor size, staging, and extent of hepatic injury. High-grade tumors will have a poor prognosis, while low-grade tumors may unnoticed for many years.

Track 8: Gastrointestinal Radiology

Gastrointestinal radiology has expanded its scope beyond conventional abdominal radiography, barium studies, and cholecystography. Ultrasonography allows imaging of abdominal organs and the intestine without the use of radiation. Tomography now allows comprehensive assessment of abdominal and pelvic inflammatory and infectious processes, obstruction, tumor detection and staging, and display of vasculature and blunt trauma effects that were not possible 50 years ago.  Barium enema with air contrast may be used to examining the colon to assess symptoms, including: a recent change in bowel habits, abdominal pain or rectal bleeding. Compared to a barium enema, the air contrast examination offers increased sensitivity for the detection of polyps and small masses.

Track 9: Helicobacter Pylori Infection

H. pylori are spiral-shaped bacteria that grow in the gut and have a tendency to attack the stomach epithelial lining. H. pylori infections are usually harmless, but they’re responsible for the majority of ulcers in the stomach and small intestine. While infections with this strain of bacteria typically don’t cause symptoms, they can lead to diseases in some people, including peptic ulcers, and an inflammatory condition inside the stomach known as gastritis. Due to the spiral-shaped of H. pylori, it penetrates the stomach lining, where they are protected by mucus and your body’s immune cells are not able to reach them. The bacteria can interfere with your immune response and ensure that they’re not destroyed. This can lead to stomach problems.

Track 10:  Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's disease and ulcerative colitis are the major types of inflammatory bowel disease. It is mainly to note that not only the Crohn's disease affect the intestine; it can also affect the buccal cavity, oesophagus, stomach and the anus whereas ulcerative colitis primarily affects the colon and rectum. Inflammatory bowel diseases belongs to the class of autoimmune diseases, in which the body’s own immune system attacks elements of the gastrointestinal system.

Track 11: Pancreatic Diseases

The pancreas is a gland which produces juices that help break down food and hormones and help control blood sugar levels. There are two forms of pancreatitis, which are differs in their causes and symptoms, and require different treatment. Acute pancreatitis is a rapid-onset inflammation of the pancreas, most frequently caused by alcoholism or gallstones. Chronic pancreatitis is a long-standing inflammation of the pancreas. This occurs when digestive enzymes starts digesting the pancreas itself. Pancreatic cancer, Cystic fibrosis, a genetic disorder in which thick, sticky mucus may also block the tubes in pancreas.

Track 12: Bariatric Surgery

Bariatric surgery is a weight loss surgery includes a variety of procedures performed to the people who have obesity. Weight loss is achieved by reducing the size of the stomach with a gastric band or through removal of a portion of the stomach (sleeve gastrectomy or biliopancreatic diversion with duodenal switch) or by resecting and re-routing the small intestine to a small stomach pouches (gastric bypass surgery).

Track 13: Gastroesophageal Reflux Malady

Gastroesophageal Reflux Malady or Gastroesophageal reflux disease - GERD, is a digestive turmoil that affects the lower oesophageal sphincter, the ring of muscle between the oesophagus and stomach. Many individuals experience the ill effects of indigestion or corrosive heartburn brought on by GERD Reflux intends to stream back or return. Along these lines, gastroesophageal reflux is the arrival of the stomach's substance move down into the throat. In typical processing, the lower oesophageal sphincter opens to enable sustenance to go into the stomach and closes to avoid nourishment and acidic stomach juices from streaming once more into the throat. Gastroesophageal reflux happens when the LES is feeble or unwinds improperly, enabling the stomach's substance to stream up into the oesophagus.

Track 14: Gastrointestinal Endoscopy

Endoscopy is an examination using a tube-like device with a light on the end. A camera at the end of the tube transmits the lighted image before the tube to a "TV" screen so the examiner can observe the inside of the upper alimentary tract as the tube advances. At the examiner’s end of the instrument, there are controls that direct the other end, pump air into the stomach, clear the view with water, or suck out unwanted content. The most common indications are dyspepsia (upper abdominal pain), persistent heartburn, acute bleeding from the upper git, and anaemia. The most common findings are stomach or duodenal ulcer or esophagitis (inflammation of the oesophagus).

Track 15: Gastrointestinal Immunology

The gastrointestinal (GI) tract is the only organ whose function is controlled by its own intrinsic enteric nervous system (ENS), but it is additionally regulated by extrinsic (sympathetic and parasympathetic) innervation. The GI nervous and immune systems are highly incorporated in their common goal, which is to unite digestive functions with protection from ingested environmental threats. This review discusses the physiological importance of enteric neuroimmune integration by summarizing the current knowledge of developmental pathways, cellular organization, and molecular mechanisms of neuroimmune interactions in health and ailments. Gut Immunology test verifies the immune response in the gut by measuring two biomarkers, calprotectin and eosinophil protein X (EPX). The normal and inflammated intestine contains many specific immune cells, including IgA-secreting plasma cells, CD4+ and CD8+ T cells, regulatory T cells and gdT cells.

Track 16: Neurogastroenterology and Motility

Neurogastroenterology includes the study associated with brain, the alimentary canal, and their interactions with significance to the comprehension and management of gastrointestinal motility and functional GI disorders. Neurogastroenterology concentrates on the functions, malfunctions, and the malformations of the sympathetic, parasympathetic, and enteric divisions of the digestive tract.

Summary

Gastroenterologists 2019 highlights the theme “Multidisciplinary Approach and Innovations in Gastroenterology”. It fundamentally concentrates on the most recent symptomatic and restorative methods for gastric ailments. It examines the most recent research results in the field of gastroenterology and unites gastroenterologists, gastrology surgeons, doctors, researchers, understudies alongside modern and drug store experts to share their perspectives on basic parts of gastroenterology research.

For more details please visit - http://gastroenterologists.conferenceseries.com/

Why Gastroenterologists 2019?

With individuals from around the globe concentrated on finding out about most recent analytic and treatment methodology of different gastrointestinal ailments and all the related parts of gastrointestinal tract. This is your best chance to achieve the biggest array of members from the whole world. From the conference and discourse of the famous individuals of Gastroenterologists conference 2019, you can refresh your insight about current circumstance of gastroenterology and get name and acknowledge at this 2-day event.

Target Audience

The intended interest group incorporate Gastroenterologists, General professionals, Paediatricians, Internal drug authorities, Surgeons and Academicians, Pharmaceutical Representatives, clinical research organizations and symptomatic specialist organizations.

  Hospitals 40%

  Academia/Research 30%

  Industry 30%

Gastroenterology Associated Universities in Australia

•  The University of New Castle Australia
•  University of Queensland
•  Flinders University
•  Monash University
•  University of Sydney
•  Australian National University   
•  Macquarie University Hospital

Companies Associated with Gastroenterology in Australia

•   Takeda Pharmaceuticals
•   Pentax Medical
•   Inova Pharm,aceuticals
•   AFT Pharmaceuticals
•   Ferring Pharmaceuticals
•   Aspen Australia
•   Allergan
•   Astrazeneca
•  Axent Medical
•  Janssen Australia
•  Mylan Pharmaceuticals
•  Tillotts Pharma
•  Adare Pharmaceuticals
•  Aurobindo Pharma
•  Synergy Pharmaceuticals

Gastroenterology Hospitals in Australia

•  Queen Elizabeth Hospital
• Queen Elizabeth Hospital
• Westmead Hospitals
• St Vincent’s Hospital
• Wesley Hospital
• Queensland Gastroenterology
• Wexford Gastroenterology
• Penant Hills Gastroenterology
• Princess Alexandra Hospital
• Bundaberg Base Hospital
• Nepean Hospital
• Monash Children's Hospital
• Southside Endoscopy Centre
• Mount Hospital
• Mater Hospital Brisbane
• Glen Iris
• Macquarie Hospital
• Monserrat Day Hospitals

Global Outlook of the Gastrointestinal Therapeutics

The worldwide gastrointestinal therapeutics showcase estimate was esteemed at USD 51.9 billion out of 2016 and is slated to grow at a lucrative CAGR of 6.6% over the figure time frame. Expanding reception of biologics for treatment of gastrointestinal maladies is the essential driver of the market. As per the Centers for Disease Control and Prevention (CDC), it is evaluated that around 1-1.3 million individuals are experiencing Inflammatory Bowel Disease (IBD) in U.S. Commonness of Crohn's infection and ulcerative colitis is 201 for each 100,000 adults and 238 for every 100,000 adults, respectively.

An extensive variety of new generation therapeutics focuses on that incorporate novel little particles and cell treatment are right now under scrutiny. These incorporate tofacitinib, ustekinumab, mongersen, and vedolizumab. This influx is foreseen to be a result of high commonness of gastrointestinal infections all inclusive. Vedolizumab is rising as a first-line biologic treatment for Crohn's malady. Presently, the U.S. FDA has endorsed Humira, Amjevita, Cimzia, Remicade, Renflexis, Inflectra, Tysabri, and Entyvio for the treatment of Crohn's illness.

A few examinations have demonstrated that biologics display more prominent long term effectiveness. As per an investigation led by University of Chicago, use of biologics has brought about a general abatement in the quantity of medical procedures by around 40.0%, crisis room visits by 60.0%, and hospitalizations by 50.0%.

So also, the National Institute did an examination on viability of infliximab in treatment for Health Research and it was accounted for to be a cost-effective solution in episodic treatment of Crohn's Disease. Expanding requirement for cost control in medicates advancement and additionally organization costs is probably going to fuel development opprtunity for biologics. Approach of focused treatment choices has prompted improvement of more customized biologics.